1.47
1.47 (-4.58%)
As of Jun 14, 2022
Effector Therapeutics, Inc. [EFTR]
Source:
Company Overview
Effector Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs we refer to as STRIs. Translation is the process in cells whereby the synthesis of proteins is directed by information contained in genetic sequences.
Country | United States |
Headquarters | solana beach, california |
Phone Number | (858) 925-8215 |
Industry | |
CEO | Stephen Worland |
Website | www.effector.com |